ASTMH 2019

68th Annual Meeting

20-24 November 2019
National Harbor, USA

The American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting is designed for researchers, professors, government and public health officials, military personnel, travel clinic physicians, practicing physicians in tropical medicine, students and all health care providers working in the fields of tropical medicine, hygiene and global health.

 

You can find DNDat Booth #410!

Download DNDi @ ASTMH 2019

Symposia

New tools to accelerate elimination of onchocerciasis

Date: Sunday, 24 November 2019
Time: 8:00-9:45
Room: National Harbor 11 (National Harbor Level) 

Co-chairs: Sara Lustigman, Head of Molecular Parasitology Lab, NY Blood Center, USA and Annie Mo, NIAID, NIH, USA

Accelerating elimination of NTDs in AFRICA: Onchocerciasis
Maria Rebollo Polo, Head of ESPEN, WHO Africa, DRC
Macrofilaricidal drug development – onwards and upwards
Sabine Specht, Head Filarial Diseases, DNDi, Switzerland

Prophylactic vaccine and vaccine linked-chemotherapy to protect against new infections
Sara Lustigman, Head of Molecular Parasitology Lab, NY Blood Center, USA

Biomarkers for infections and success of elimination
Tom Nutman, NIAID, NIH, USA

Overview of resources available for transnational research
Annie Mo, NIAID, NIH, USA

 

Exploring the range of clinical efforts to identify repurposed drugs for neglected infectious diseases

Date: Sunday, 24 November 2019
Time: 11:15-13:00
Room: Maryland B (Ballroom Level)

Chair: Parvesh Paul, NCATS/NIH, Rockville, MD, United States

CURE ID: A mobile app for capturing case reports directly from clinicians globally of repurposed drugs for infectious diseases
Parvesh Paul, NCATS/NIH, Rockville, MD, United States

Cures within reach – Small scale clinical trials of repurposed drugs in developing countries
Clare Thibodeaux, Cures Within Reach, Chicago, IL, United States

DNDi: Clinical trials of repurposed drugs in novel combinations, doses and routes, and identification of new compounds
Nathalie Strub-Wourgaft, NTD Director, DNDi, Switzerland

Meta-analyses of individual patient data from clinical trials
Philippe J. Guerin, University of Oxford, Oxford, United Kingdom

 

 

Oral presentations

Date: Thursday, 21 November 2019
Time: 13:45-14:00
Room: National Harbor 11 (National Harbor Level)

Association of pre-control infection prevalence of lymphatic filariasis with clinical morbidity
Vinkeles Melchers NV*, Stolk WA , Pedrique B , Vanhommerig JW, Coffeng LE , de Vlas SJ

 

Date: Friday, 22 November 2019
Time: 14:15-14:30
Room: National Harbor 11 (National Harbor Level)

Drug development for the treatment and control of onchocerciasis: A population pharmacokinetic analysis of emodepside (BAY 44-4400) in healthy volunteers
Assmus F*, Hoglund RM, Scandale I, Tarning J

 

Date: Friday, 22 November 2019
Time: 16:00-16:15
Room: National Harbor 2 (National Harbor Level)

Estimation of incidence rate of mortality for antileishmanial therapies: A systematic review of published literature from 1980 to 2018
Singh S*, Dahal P, Ngu R, Maguire B, Olliaro P, Stepniewska K, Halleux C, Alves F

 

 

Posters

Date: Saturday, 23 November 2019
Time: 12:00-13:45
Room: Prince George’s Exhibit Hall D (Lower Atrium Level)

Evaluating new regimens for the treatment of chronic Chagas disease: The BENDITA trial  
Barreira FBlum B, Garcia W, Gascón J, Ortiz L, Torrico F, Sosa-Estani S

Comparative evaluation of conventional, quantitative and droplet digital PCR for the molecular diagnosis of Chagas disease
Nath-Chowdhury M, Ndao M, Chatelain E, Strong C, Scott-Lourenço M

 

 

More information: